APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug Safety and Pharmacovigilance (PV) Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drug Safety and Pharmacovigilance (PV) Software Industry Growth and Trends Forecast to 2032

Report ID 174123180115 April 2026113 pages

Choose your research edition.

Industry ResearchDrug Safety and Pharmacovigilance (PV) Software Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Safety and Pharmacovigilance (PV) Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Drug Safety and Pharmacovigilance (PV) Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Safety and Pharmacovigilance (PV) Software Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Drug Safety and Pharmacovigilance (PV) Software Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

According to APO Research, the global Drug Safety and Pharmacovigilance (PV) Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drug Safety and Pharmacovigilance (PV) Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drug Safety and Pharmacovigilance (PV) Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Safety and Pharmacovigilance (PV) Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drug Safety and Pharmacovigilance (PV) Software market include Oracle, Veeva Systems, ArisGlobal, IQVIA, EXTEDO, RxLogix, Ennov, Uppsala Monitoring Centre and Medidata, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drug Safety and Pharmacovigilance (PV) Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drug Safety and Pharmacovigilance (PV) Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Safety and Pharmacovigilance (PV) Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Safety and Pharmacovigilance (PV) Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drug Safety and Pharmacovigilance (PV) Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drug Safety and Pharmacovigilance (PV) Software Market by Company

Oracle

Veeva Systems

ArisGlobal

IQVIA

EXTEDO

RxLogix

Ennov

Uppsala Monitoring Centre

Medidata

Clarivate

AB Cube

Cloudbyz

Cognizant Technology

Taimei Technology

eMedyun

Bioknow

Singedi Health

Drug Safety and Pharmacovigilance (PV) Software Segment by Type

On-Premises

Cloud-Based

Drug Safety and Pharmacovigilance (PV) Software Segment by Application

Pharma and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Other

Drug Safety and Pharmacovigilance (PV) Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Safety and Pharmacovigilance (PV) Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Safety and Pharmacovigilance (PV) Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Safety and Pharmacovigilance (PV) Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drug Safety and Pharmacovigilance (PV) Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2021-2026) Table 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2027-2032) Table 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2026) Table 9. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2026) Table 24. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drug Safety and Pharmacovigilance (PV) Software Industry Trends Table 37. Drug Safety and Pharmacovigilance (PV) Software Industry Drivers Table 38. Drug Safety and Pharmacovigilance (PV) Software Industry Opportunities and Challenges Table 39. Drug Safety and Pharmacovigilance (PV) Software Industry Restraints Table 40. Global Drug Safety and Pharmacovigilance (PV) Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drug Safety and Pharmacovigilance (PV) Software Revenue Market Share by Company (2021-2026) Table 42. Global Drug Safety and Pharmacovigilance (PV) Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drug Safety and Pharmacovigilance (PV) Software Key Company Headquarters & Area Served Table 44. Global Drug Safety and Pharmacovigilance (PV) Software Company, Product Type & Application Table 45. Global Drug Safety and Pharmacovigilance (PV) Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drug Safety and Pharmacovigilance (PV) Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Oracle Company Information Table 49. Oracle Business Overview Table 50. Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Oracle Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 52. Oracle Recent Development Table 53. Veeva Systems Company Information Table 54. Veeva Systems Business Overview Table 55. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 57. Veeva Systems Recent Development Table 58. ArisGlobal Company Information Table 59. ArisGlobal Business Overview Table 60. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 62. ArisGlobal Recent Development Table 63. IQVIA Company Information Table 64. IQVIA Business Overview Table 65. IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 67. IQVIA Recent Development Table 68. EXTEDO Company Information Table 69. EXTEDO Business Overview Table 70. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 72. EXTEDO Recent Development Table 73. RxLogix Company Information Table 74. RxLogix Business Overview Table 75. RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 77. RxLogix Recent Development Table 78. Ennov Company Information Table 79. Ennov Business Overview Table 80. Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Ennov Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 82. Ennov Recent Development Table 83. Uppsala Monitoring Centre Company Information Table 84. Uppsala Monitoring Centre Business Overview Table 85. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 87. Uppsala Monitoring Centre Recent Development Table 88. Medidata Company Information Table 89. Medidata Business Overview Table 90. Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Medidata Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 92. Medidata Recent Development Table 93. Clarivate Company Information Table 94. Clarivate Business Overview Table 95. Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 97. Clarivate Recent Development Table 98. AB Cube Company Information Table 99. AB Cube Business Overview Table 100. AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 102. AB Cube Recent Development Table 103. Cloudbyz Company Information Table 104. Cloudbyz Business Overview Table 105. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 107. Cloudbyz Recent Development Table 108. Cognizant Technology Company Information Table 109. Cognizant Technology Business Overview Table 110. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 112. Cognizant Technology Recent Development Table 113. Taimei Technology Company Information Table 114. Taimei Technology Business Overview Table 115. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 117. Taimei Technology Recent Development Table 118. eMedyun Company Information Table 119. eMedyun Business Overview Table 120. eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 122. eMedyun Recent Development Table 123. Bioknow Company Information Table 124. Bioknow Business Overview Table 125. Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 127. Bioknow Recent Development Table 128. Singedi Health Company Information Table 129. Singedi Health Business Overview Table 130. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Portfolio Table 132. Singedi Health Recent Development Table 133. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2026) Table 136. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Country (2027-2032) Table 138. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2026) Table 141. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2026) Table 146. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Country (2027-2032) Table 148. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2026) Table 151. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2026) Table 156. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drug Safety and Pharmacovigilance (PV) Software Product Image Figure 3. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drug Safety and Pharmacovigilance (PV) Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region: 2025 VS 2032 Figure 6. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Region (2021-2032) Figure 7. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. On-Premises Image Figure 13. Global On-Premises Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cloud-Based Image Figure 15. Global Cloud-Based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Type 2025 VS 2032 Figure 18. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2032) Figure 19. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2032) Figure 21. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Type (2021-2032) Figure 23. Pharma and Biotech Companies Image Figure 24. Global Pharma and Biotech Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Contract Research Organizations (CROs) Image Figure 26. Global Contract Research Organizations (CROs) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Business Process Outsourcing (BPO) Firms Image Figure 28. Global Business Process Outsourcing (BPO) Firms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Drug Safety and Pharmacovigilance (PV) Software Market Share by Application 2025 VS 2032 Figure 33. North America Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2032) Figure 34. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2032) Figure 36. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Drug Safety and Pharmacovigilance (PV) Software Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2032) Figure 43. Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2032) Figure 46. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2032) Figure 49. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2032) Figure 52. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premises
  • Cloud-Based
Applications
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPO) Firms
  • Other
Companies covered
  • Oracle
  • Veeva Systems
  • ArisGlobal
  • IQVIA
  • EXTEDO
  • RxLogix
  • Ennov
  • Uppsala Monitoring Centre
  • Medidata
  • Clarivate
  • AB Cube
  • Cloudbyz
  • Cognizant Technology
  • Taimei Technology
  • eMedyun
  • Bioknow
  • Singedi Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drug Safety and Pharmacovigilance (PV) Software Market Size (2021-2032)
  8. 1.5.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (2021-2032)
2 Drug Safety and Pharmacovigilance (PV) Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 On-Premises
  3. 2.1.2 Cloud-Based
  4. 2.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Type
  5. 2.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions
  9. 2.3.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Type (2021-2026)
3 Drug Safety and Pharmacovigilance (PV) Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharma and Biotech Companies
  3. 3.1.2 Contract Research Organizations (CROs)
  4. 3.1.3 Business Process Outsourcing (BPO) Firms
  5. 3.1.4 Other
  6. 3.2 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Application
  7. 3.2.1 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Drug Safety and Pharmacovigilance (PV) Software Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Drug Safety and Pharmacovigilance (PV) Software Market Size by Regions
  11. 3.3.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drug Safety and Pharmacovigilance (PV) Software Industry Trends
  2. 4.2 Drug Safety and Pharmacovigilance (PV) Software Industry Drivers
  3. 4.3 Drug Safety and Pharmacovigilance (PV) Software Industry Opportunities and Challenges
  4. 4.4 Drug Safety and Pharmacovigilance (PV) Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drug Safety and Pharmacovigilance (PV) Software Revenue (2021-2026)
  2. 5.2 Global Drug Safety and Pharmacovigilance (PV) Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drug Safety and Pharmacovigilance (PV) Software Key Company Headquarters & Area Served
  4. 5.4 Global Drug Safety and Pharmacovigilance (PV) Software Company, Product Type & Application
  5. 5.5 Global Drug Safety and Pharmacovigilance (PV) Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drug Safety and Pharmacovigilance (PV) Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drug Safety and Pharmacovigilance (PV) Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drug Safety and Pharmacovigilance (PV) Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Oracle
  2. 6.1.1 Oracle Company Information
  3. 6.1.2 Oracle Business Overview
  4. 6.1.3 Oracle Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Oracle Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  6. 6.1.5 Oracle Recent Developments
  7. 6.2 Veeva Systems
  8. 6.2.1 Veeva Systems Company Information
  9. 6.2.2 Veeva Systems Business Overview
  10. 6.2.3 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Veeva Systems Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  12. 6.2.5 Veeva Systems Recent Developments
  13. 6.3 ArisGlobal
  14. 6.3.1 ArisGlobal Company Information
  15. 6.3.2 ArisGlobal Business Overview
  16. 6.3.3 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 ArisGlobal Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  18. 6.3.5 ArisGlobal Recent Developments
  19. 6.4 IQVIA
  20. 6.4.1 IQVIA Company Information
  21. 6.4.2 IQVIA Business Overview
  22. 6.4.3 IQVIA Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 IQVIA Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  24. 6.4.5 IQVIA Recent Developments
  25. 6.5 EXTEDO
  26. 6.5.1 EXTEDO Company Information
  27. 6.5.2 EXTEDO Business Overview
  28. 6.5.3 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 EXTEDO Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  30. 6.5.5 EXTEDO Recent Developments
  31. 6.6 RxLogix
  32. 6.6.1 RxLogix Company Information
  33. 6.6.2 RxLogix Business Overview
  34. 6.6.3 RxLogix Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 RxLogix Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  36. 6.6.5 RxLogix Recent Developments
  37. 6.7 Ennov
  38. 6.7.1 Ennov Company Information
  39. 6.7.2 Ennov Business Overview
  40. 6.7.3 Ennov Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Ennov Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  42. 6.7.5 Ennov Recent Developments
  43. 6.8 Uppsala Monitoring Centre
  44. 6.8.1 Uppsala Monitoring Centre Company Information
  45. 6.8.2 Uppsala Monitoring Centre Business Overview
  46. 6.8.3 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Uppsala Monitoring Centre Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  48. 6.8.5 Uppsala Monitoring Centre Recent Developments
  49. 6.9 Medidata
  50. 6.9.1 Medidata Company Information
  51. 6.9.2 Medidata Business Overview
  52. 6.9.3 Medidata Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Medidata Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  54. 6.9.5 Medidata Recent Developments
  55. 6.10 Clarivate
  56. 6.10.1 Clarivate Company Information
  57. 6.10.2 Clarivate Business Overview
  58. 6.10.3 Clarivate Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Clarivate Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  60. 6.10.5 Clarivate Recent Developments
  61. 6.11 AB Cube
  62. 6.11.1 AB Cube Company Information
  63. 6.11.2 AB Cube Business Overview
  64. 6.11.3 AB Cube Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AB Cube Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  66. 6.11.5 AB Cube Recent Developments
  67. 6.12 Cloudbyz
  68. 6.12.1 Cloudbyz Company Information
  69. 6.12.2 Cloudbyz Business Overview
  70. 6.12.3 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Cloudbyz Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  72. 6.12.5 Cloudbyz Recent Developments
  73. 6.13 Cognizant Technology
  74. 6.13.1 Cognizant Technology Company Information
  75. 6.13.2 Cognizant Technology Business Overview
  76. 6.13.3 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cognizant Technology Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  78. 6.13.5 Cognizant Technology Recent Developments
  79. 6.14 Taimei Technology
  80. 6.14.1 Taimei Technology Company Information
  81. 6.14.2 Taimei Technology Business Overview
  82. 6.14.3 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Taimei Technology Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  84. 6.14.5 Taimei Technology Recent Developments
  85. 6.15 eMedyun
  86. 6.15.1 eMedyun Company Information
  87. 6.15.2 eMedyun Business Overview
  88. 6.15.3 eMedyun Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 eMedyun Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  90. 6.15.5 eMedyun Recent Developments
  91. 6.16 Bioknow
  92. 6.16.1 Bioknow Company Information
  93. 6.16.2 Bioknow Business Overview
  94. 6.16.3 Bioknow Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bioknow Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  96. 6.16.5 Bioknow Recent Developments
  97. 6.17 Singedi Health
  98. 6.17.1 Singedi Health Company Information
  99. 6.17.2 Singedi Health Business Overview
  100. 6.17.3 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Singedi Health Drug Safety and Pharmacovigilance (PV) Software Product Portfolio
  102. 6.17.5 Singedi Health Recent Developments
7 North America
  1. 7.1 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
  3. 7.3 North America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
  3. 8.3 Europe Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
  3. 10.3 South America Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drug Safety and Pharmacovigilance (PV) Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst